【正文】
ica and India[J]. Int J Cancer,2008,123(1):153160. [18] Munoz N,Bosch FX,de Sanjose S,et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer[J]. N Engl J Med,2003,348(6):518527. [19] Wallin KL,Wiklund F,Angstoom T,et al. Typespecific persistence of human papillomavirus dna before the development of invasive cervical cancer[J]. N Engl J Med,1999,341(22):16331638. [20] Huh WK. Human papillomavirus infection:A Concise Review of Natural History[J]. Obstet Gynecol,2009,114(1):139143. [21] Newton R,Ziegler J,Casabonne D,et al. A case control study of cancer of the uterine cervix in Uganda[J]. Eur J Cancer Prev,2007,16(6):555558. [22] Plummer M,Appley P,Beral V,et al. Cervical carcinoma and sexual behavior:Collaborative reanalysis of individual data on 15,461 women without cervical carcinoma from 21 epidemiological studies[J]. Cancer Epidemiol Biomarkers Prev,2009,18(4):10601069. [23] Pinto LA,Viscid R,Harro CD,et al. Cellular immune response to UPV1831,and53 in healthy volunteers immunized with rebinant HPV16 L1 viruslike particles[J]. Virology,2006,353(2):451462. [24] Castle PE,Sideri M,Jeronimo J,et al. Risk assessment to guide the prevention of cervical cancer[J]. J Low Genit Tract Dis,2008,12(1):17. [25] Katki HA,Wacholder S,Solomon D,et al. Risk estimation for the next generation of prevention programmes for cervical cancer[J]. Lancet Oncol,2009,10(11):10221023. ?。ㄊ崭迦掌冢?0160920)內(nèi)容總結(jié) (1)宮頸癌篩查風(fēng)險(xiǎn)評(píng)估量表的可行性研究 [摘要] 目的